Ancient herbal mix tested for stubborn eczema in small trial

NCT ID NCT04686955

Completed Disease control Sponsor: Taipei Veterans General Hospital, Taiwan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed Phase 3 trial tested a Chinese herbal formula called Xiao-Xian-Gui-Fu-Tang in 19 people aged 6 to 30 with moderate to severe atopic dermatitis (eczema). Participants took the herbal blend or a placebo for several weeks. Researchers measured changes in eczema severity and quality of life. The study aims to see if adding traditional Chinese medicine can help control this chronic skin condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Xiao-Xian-Gui-Fu-Tang (a blend of Chinese herbs including Xiao-Feng-San, Dang-Gui-Yin-Zi, Bai-Xian-Pi, and Di-Fu-Zi)
What this could lead to: If effective, this herbal formula could offer an additional treatment option for people with moderate to severe atopic dermatitis, potentially reducing symptoms and improving quality of life.
What could go wrong: This is a very small Phase 3 trial with only 19 participants, so results may not apply to a broader population. The study is completed but no results are posted yet, and the herbal mixture may cause side effects or interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

Center for Traditional Medicine, Taipei VGH

Taipei, 11217, Taiwan
Taipei Veterans General Hospital

Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.